- Home
- Publications
- Publication Search
- Publication Details
Title
Artificial intelligence, drug repurposing and peer review
Authors
Keywords
-
Journal
NATURE BIOTECHNOLOGY
Volume 38, Issue 10, Pages 1127-1131
Publisher
Springer Science and Business Media LLC
Online
2020-09-15
DOI
10.1038/s41587-020-0686-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Of chloroquine and COVID-19
- (2020) Franck Touret et al. ANTIVIRAL RESEARCH
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach
- (2020) Praveen Tilangi et al. LANCET INFECTIOUS DISEASES
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies
- (2020) Myura Nagendran et al. BMJ-British Medical Journal
- Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
- (2020) Wei Tang et al. BMJ-British Medical Journal
- Use of Baricitinib in Patients with Moderate and Severe COVID-19
- (2020) Boghuma K Titanji et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis
- (2020) Dong Huang et al. JOURNAL OF MEDICAL VIROLOGY
- Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning
- (2020) Xiangxiang Zeng et al. JOURNAL OF PROTEOME RESEARCH
- No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
- (2020) J.M. Molina et al. MEDECINE ET MALADIES INFECTIEUSES
- Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence
- (2020) Myron S. Cohen NEW ENGLAND JOURNAL OF MEDICINE
- Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
- (2020) Alexandre B. Cavalcanti et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication
- (2020) Franck Touret et al. Scientific Reports
- Pandemic publishing poses a new COVID-19 challenge
- (2020) Adam Palayew et al. Nature Human Behaviour
- Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
- (2020) Mayla Gabriela Silva Borba et al. JAMA Network Open
- DeepFam: deep learning based alignment-free method for protein family modeling and prediction
- (2018) Seokjun Seo et al. BIOINFORMATICS
- Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data
- (2016) Alexander Aliper et al. MOLECULAR PHARMACEUTICS
- Computational and Practical Aspects of Drug Repositioning
- (2015) Tudor I. Oprea et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Lancet retracts 12-year-old article linking autism to MMR vaccines
- (2010) L. Eggertson CANADIAN MEDICAL ASSOCIATION JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now